Skip to main content

Ralph R Weichselbaum

NIH Rank #4135
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1888723Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Radiology
  • CHEMISTRY

NIH Funding · FY2024

Linked Award Amount
$2.3M
Full award amounts, FY2024
Award Records
6
Records listing this PI
Award-Linked Rank
#4,135
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ralph R Weichselbaum. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Ralph R Weichselbaum as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA292860-01R01
    Genetically-engineered Bacteria Overcome Therapy Resistance
    $581.1K
    award amount
  • 5R01CA253655-05R01
    Nanoscale Metal-Organic Frameworks Enable Radiotherapy-Radiodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Generate Tumor Vaccines and Potentiate Immunotherapy of Head and Neck Cancers
    $479.1K
    award amount
  • 5R01CA276307-02R01
    Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
    $423.8K
    award amount
  • 5R01CA262508-04R01
    Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
    $392.1K
    award amount
  • 3U54CA274291-03S1U54
    A Digital Twin for rectal cancer to guide adaptive radiotherapy
    $246K
    award amount
  • 5U54CA274291-03U54
    Dynamics of Immune Response in Irradiated Rectal Cancer
    $197.5K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Ralph R Weichselbaum as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Chicago
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4135
  6. 2024
    Entered Top 25% Nationally
    Ranked #4135
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2025
    R01 Grant Holder
  9. 2025
    Program/Center Grant Leader
  10. 2026
    $5M Cumulative Funding
  11. 2026
    Entered Top 10% Nationally
    Ranked #1247